ArticleFrontiers in sports and active living2025
The influence of cereboost on mood, cognitive function, and simulated driving in professional race car drivers.
Article in Frontiers in sports and active living, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Race car driving is a physically and cognitively demanding sport requiring rapid decision-making under extreme conditions. While physical training and hydration strategies have been explored, few studies have investigated nutritional interventions to enhance cognitive or driving performance. This study examined the effects of Cereboost, an American Ginseng extract, on mood, cognitive function, and simulated driving performance in professional race car drivers. Methods: Fifty-eight licensed drivers completed a four-phase, within-subjects protocol (baseline, acute, chronic, and acute-on-chronic) involving 200 mg/day Cereboost supplementation. Assessments included validated mood questionnaires, cognitive testing via the Senaptec Sensory Station (spatial memory and split attention), and 30-minute sessions in a professional-grade racing simulator. Statistical analyses included ANOVA with Holm-Bonferroni corrections. Results: Cereboost had no statistically significant effects on mood or cognitive function after correction for multiple comparisons. However, acute-on-chronic supplementation significantly improved simulated driving performance, with a 3-second reduction in lap time and faster throttle application in corners (adjusted Conclusion: While Cereboost did not significantly alter mood or cognitive test outcomes, sustained supplementation enhanced simulated driving performance in professional drivers. These findings suggest potential benefits of nootropic supplementation for motorsport performance, warranting further investigation in on-track settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.